Thus, our results indicate that clonal bone marrow progenitors of MDS patients responding to AZA treatment exhibit this hypermethylation pattern of CpG326 of ZBTB7A, that is correlated with increased HbF levels. Here, ZBTB7A is linked to myelodysplastic syndrome.